2.9.8 NSI-189

NSI-189 #

Common Nomenclature NSI-189
Street & Reference Names N/A
Reference Dosage N/A
Maximum Dose Experienced 40mg+20mg
Form Pill
RoA Oral
Source / Jurisdiction Internet / UK


NSI-189 has been researched and investigated as a potential antidepressant, and as an agent for the treatment of cognitive impairment and neurodegeneration. Its efficacy has been vigorously debated over a number of years.

I pursued and sampled it following positive reports across a couple of specialist Internet forums.

Hardly surprisingly from a single experiment, I noticed very little. Like most nootropics it isn’t geared for recreational use.

Whilst I experienced no ill or negative effects, it is unlikely that I will return to it for any further testing.